All Updates

All Updates

icon
Filter
Funding
​​Formo raises USD 61 million in Series B funding for international expansion
Plant-based Dairy & Egg
Sep 10, 2024
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Partnerships
Funding
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Sep 10, 2024

​​Formo raises USD 61 million in Series B funding for international expansion

Funding

  • Formo (formerly known as Legendairy Foods), a German fermented cheese alternatives producer, has raised USD 61 million in Series B funding. Participants included existing investors Foodlabs, EQT Ventures, Lowercarbon Capital, Happiness Capital, Elevat3 Capital, and Grazia Capital, as well as new investors Sazaby League, Seven Ventures, Woodline Partners, The Nature Conservancy, and REWE Group.

  • The funding will be used for international expansion, product range diversification, revenue growth, and achieving net profitability by 2027. Formo also aims to accelerate the commercialization of animal-free casein for hard cheese production.

  • In addition to the funding round, Formo has launched two cheese alternatives, Frischhain and Camembritz, in over 2,000 REWE, BILLA, and METRO stores in Germany and Austria. The company uses koji, a fungus traditionally used in Japanese cuisine, to produce sustainable cheese alternatives that claim to generate fewer emissions and use less land and water than dairy cheese.

  • Analyst QuickTake: This funding round brings the total funds raised by Formo to ~USD 115 million, making it one of the highest-funded alternative cheese producers. Moreover, launching its products in 2,000+ stores in its commercial debut highlights the potential of its products and could lead to further investments.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.